Chlorzoxazone recalls
The FDA has published 2 recalls involving Chlorzoxazone since 2021. The latest was reported on 29 Sep 2021. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Sep 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why chlorzoxazone is recalled
Companies
By year
All chlorzoxazone recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Chlorzoxazone Tablets USP 375 mg recalled by Glenmark Pharmaceuticals | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Chlorzoxazone Tablets USP 750 mg recalled by Glenmark Pharmaceuticals | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Chlorzoxazone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.